4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-26-000074
Chief Technology Officer sold 40,000 shares at an average $38.31 ($1,532,309)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stout Jay S Chief Technology Officer | 2026-06-26 | Sale | −33,277 | $38.18 | $1,270,516 | 218,408 | D |
| Stout Jay S Chief Technology Officer | 2026-06-26 | Sale | −6,723 | $38.94 | $261,794 | 211,685 | D |
| Open-market sales · 40,000 sh · avg $38.31 · $1,532,309 | |||||||
Loading xslF345X06/wk-form4_1782517552.xml…